Given its essential role in protein synthesis, RPLP0 is being investigated as a potential therapeutic target. Inhibiting RPLP0 function could disrupt protein production in cancer cells, leading to cell death. However, because RPLP0 is also crucial for normal cellular functions, therapies would need to be highly specific to avoid affecting healthy cells.
